// App-Quantinova.ai

e15720 : Lymphocyte-to-monocyte ratio for predicting gemcitabine containing chemotherapy outcomes in pancreatic cancer patients.

Researchers

Presenter

  • Liwei Wang

Principal Investigators

  • N/A

Medical Centers

  • Shanghai First People's Hospital, Shanghai Jiaotong University, Shanghai, China

Locations

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Pancreatic cancer

Biomarkers

  • Lymphocyte to monocyte ratio

Drug/Treatment

  • Gemcitabine

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final